PURE - PURE BIOSCIENCE, INC.

0.0653
0.005   8.116%

Share volume: 19,026
Last Updated: 04-25-2025
Chemicals/Misc. Chemical Products: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$0.06
0.01
0.09%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
33%
Profitability 35%
Dept financing 43%
Liquidity 24%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.46%
1 Month
-29.10%
3 Months
-11.04%
6 Months
0.46%
1 Year
0.46%
2 Year
0.46%
Key data
Stock price
$0.07
P/E Ratio 
0.00
DAY RANGE
$0.06 - $0.07
EPS 
-$0.03
52 WEEK RANGE
$0.04 - $0.10
52 WEEK CHANGE
$0.46
MARKET CAP 
8.054 M
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
06-13-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$25,895
AVERAGE 30 VOLUME 
$41,849
Company detail
CEO:
Region: US
Website: purebio.com
Employees: 10
IPO year: 2013
Issue type:
Market: OTCM
Industry: Chemicals/Misc. Chemical Products
Sector: Manufacturing

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.

Recent news
loading